WHO targets world free of cervical cancer

17 November 2020
cancer_survivor_who_image_africa

The World Health Organization (WHO) has mainly made the headlines this year in relation to the coronavirus, but its other priorities remain, as evidenced by the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer on Tuesday.

This strategy outlines three key steps for the battle against what is the fourth most common cancer among women globally, and one which is a preventable disease and curable if detected early and adequately treated.

The steps are vaccination, screening and treatment. The WHO claims that successful implementation of all three could reduce more than 40% of new cases of the disease and five million related deaths by 2050.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical